Similar reduction in ACPA serum levels have been recently reported in early RA patients treated with either MTX in combination with sulfasalazine and hydroxychloroquine or MTX in combination with infliximab [14]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.